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ABSTRACT
DNA methylation and chromatin DNaseI sensitivity
were analyzed in and adjacent to D4Z4 repeat arrays,
which consist of 1 to »100 tandem 3.3-kb units at
subtelomeric 4q and 10q. D4Z4 displayed hypo-
methylation in some cancers and hypermethylation
in others relative to normal tissues. Surprisingly, in
cancers with extensive D4Z4 methylation there was
a barrier to hypermethylation spreading to the
beginning of this disease-associated array (facios-
capulohumeral muscular dystrophy, FSHD) despite
sequence conservation in repeat units throughout
the array. We infer a different chromatin structure at
the proximal end of the array than at interior repeats,
consistent with results from chromatin DNaseI
sensitivity assays indicating a boundary element
near the beginning of the array. The relative chro-
matin DNaseI sensitivity in FSHD and control myo-
blasts and lymphoblasts was as follows: a non-genic
D4Z4-adjacent sequence (p13E-11, array-proximal)
`untranscribed gene standards`D4Z4 arrays
`constitutive heterochromatin (satellite 2;
P_10
 4 for all comparisons). Cancers displaying
D4Z4 hypermethylation also exhibited a hypermethy-
lation-resistant subregion within the 3.3-kb D4Z4
repeat units. This subregion contains runs of G that
form G-quadruplexes in vitro. Unusual DNA struc-
tures might contribute to topological constraints
that link short 4q D4Z4 arrays to FSHD and make
long ones phenotypically neutral.
INTRODUCTION
Overall hypomethylation in some cancer specimens and
hypermethylation in others was found in NBL2, a tandem
array of 1.4kb repeat units, in a comparison to diverse
somatic control tissues. We demonstrated this in ovarian
carcinomas and Wilms tumors by hairpin genomic
sequencing to analyze methylation at 14 CpG dyads and
by southern blotting to assess overall NBL2 methylation
at CpG-containing restriction sites (1). NBL2 is located
mostly in the short arms of the acrocentric chromosomes.
This large tandem array and as well as others, including
pericentromeric satellite 2 DNA and subtelomeric
D4Z4 repeat arrays, require DNA methyltransferase 3B
(DNMT3B) for normal levels of methylation (2). Satellite
2 and other human satellite DNAs are very frequently
hypomethylated in diverse cancers compared with a
wide variety of control tissues (3). There is clearly
much plasticity in the epigenetics of these tandem repeat
arrays.
The epigenetics of D4Z4 is of great interest because of
the linkage of a short array of these tandem 3.3-kb repeats
at 4q35 (Figure 1) to facioscapulohumeral muscular
dystrophy (FSHD), a severely debilitating, dominantly
inherited disease (4). In the present study, we examined
DNA methylation and chromatin structure in D4Z4 and
the immediately proximal sequence in various cell popula-
tions to gain insights into this array, whose structure must
play a central role in FSHD. The very high G+C content
of these repeat arrays, 73%, as contrasted with the
neighboring 1-kb proximal sequence, which has only
40% G+C, suggests biologically important epigenetic
features of the proximal border of the array.
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disease in an unelucidated manner. About 95% of FSHD
patients have only 1–10 tandem 3.3-kb repeat units in one
of the two allelic 4q35 arrays (5,6). Almost all unaﬀected
individuals have 11–100 of these repeat units on both 4q35
arrays. Analysis of the epigenetics of D4Z4 is facilitated by
its unusually highly conserved primary structure, com-
pared to many other types of tandem repeats, including
satellite DNAs and NBL2. D4Z4 also oﬀers the advantage
of having at its proximal border a well-characterized
0.8-kb sequence, p13E-11 (Figure 1A), a hybridization
probe for molecular diagnosis of FSHD (7–9).
FSHD is an enigmatic disease. There are subtelomeric
D4Z4 arrays at 10q as well as 4q, and both are size
polymorphic but only 4q arrays are linked to the disease.
Short 10q arrays are phenotypically neutral despite 4q and
10q D4Z4 arrays having 99% homology (GenBank
AF117653, AC126281, AL732375). Moreover, there is
495% homology in the 42kb proximal to D4Z4at 4q35
and 10q26 and also in the 15–25kb at 4q35 and 10q26 that
is distal to D4Z4 (Figure 1A) all the way to the telomeric
TTAGGG repeats (5). FSHD pathogenesis is probably
initiated by a short D4Z4 array interacting with a distant
4q35 sequence that is proximal to the array and not
present on 10q26 (10). The identity of this sequence is
unclear. From three reports of conventional microarray
expression analyses on FSHD versus control muscle cell
populations (11–13), no candidate FSHD gene present on
4q35, but not 10q26, has emerged. Moreover, 4q35 genes,
including a gene-like sequence within the D4Z4 repeat
unit, individually tested for involvement in FSHD have
produced conﬂicting results (8,11,14–17).
Because DNA methylation and chromatin structure are
often interrelated (18), insights into D4Z4 chromatin
might be derived from the study of its methylation
patterns. Shortened arrays in FSHD patients are sig-
niﬁcantly hypomethylated relative to D4Z4 arrays from
controls (19), However, they are not as hypomethylated as
the normal length D4Z4 arrays of ICF patients (20,21).
ICF patients do not show any tendency to muscular
disorders. Nonetheless, the FSHD-associated hypomethy-
lation of D4Z4 might be a marker of a less condensed
chromatin structure in disease-related short arrays (5).
Several groups reported D4Z4 hypomethylation in
cancers, cancer-derived cell lines, and cells treated with
demethylating agents or deﬁcient in DNA methyltransfer-
ase (22–24). However, interpretation of those studies is
complicated by their being PCR-based methylation
analyses in which the investigators probably mostly
detected highly abundant D4Z4-like sequences rather
than speciﬁcally D4Z4. In contrast, blot hybridization
under stringent conditions provides speciﬁcity for D4Z4
arrays (25) and oﬀers the important advantage that a
single blot can be serially hybridized with diﬀerent probes
for comparison of DNA methylation or chromatin DNase
sensitivity at diﬀerent sequences. Southern blotting also
allows individual assessment of 4q versus 10q D4Z4 arrays
by use of one of the rare sequence variations at a
restriction site that is 4q- or 10q-speciﬁc (26,27).
In this study, we observed that D4Z4 was hypermethyl-
ated in some cancers and hypomethylated in others of the
same type compared with a diverse set of somatic control
tissues. Importantly, the ﬁrst D4Z4 repeat unit behaved
very diﬀerently from the rest of the D4Z4 array with
respect to changes in DNA methylation. Moreover, the
immediately proximal chromatin had a very diﬀerent
accessibility to DNaseI than the array, suggesting a
diﬀerent chromatin structure at the proximal border
than in the body of the array. Our results are consistent
with a model that we present for the biological importance
of the proximal end of the D4Z4 array and a special
chromatin structure within the array that could be
sensitive to array length in an FSHD-determining manner.
MATERIALS AND METHODS
Tissue samples and DNA isolation
With IRB approval, primary tumor samples were
obtained from patients who had not been treated with
chemotherapy prior to surgery (28). DNA was puriﬁed
from quick-frozen samples of tumor tissue or autopsy
samples from non-cancer patients or trauma victims by
phenol-extraction and ethanol-precipitation.
Cellculture
Lymphoblastoid cell lines (LCLs 149, 724, 112 and 952)
were from normal controls (AG14953 and GM18478,
Coriell Institute for Medical Research) or FSHD patients
(GM17724, Coriell Institute, and WJ952, from Dr Silvere
van der Maarel) and propagated in RPMI 1640
(Invitrogen) with 15% fetal bovine serum (FBS,
Invitrogen). Normal-control skin ﬁbroblast cell strains
996 and CF702 (GM01996, Coriell Institute, and Tulane
Health Science Center, respectively) were derived from
skin punch biopsies from non-FSHD patients and grown
Figure 1. Maps of the studied D4Z4 and proximal regions. (A) Cartoon
(not to scale) showing the size-polymorphic D4Z4 array and p13E-11,
a marker sequence. The sequence between the D4Z4 array and the
telomeric hexamer repeats is about 15–25kb. Black or gray trapezoids,
essentially identical, tandem D4Z4 repeat units (3.3-kb KpnI frag-
ments). White trapezoid, the 0.9-kb region from the start of the array
to the ﬁrst KpnI site in D4Z4. (B) Maps of StyI sites for chromatin
DNaseI sensitivity assays. Left, StyI restriction map of the proximal
border of D4Z4 including the StyI fragment spanning the 0.8-kb
p13E-11 sequence through 0.3kb at the beginning of D4Z4. Right, StyI
restriction map comparing 4q35 and 10q26 D4Z4 repeat units.
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L-glutamine. The FSHD myoblast cell strain (FM41j)
was derived from a moderately aﬀected, left deltoid biopsy
of an FSHD patient. Duly signed patient consent forms
were obtained that had been approved by the Institutional
Review Boards of Tulane Health Science Center and the
University of Mississippi Medical Center in Jackson. The
fetal myoblast cell strain (H246) from Dr Stephen
Hauschka was derived in 1980 from an anonymous,
therapeutically aborted E-79 fetus under a signed patient
consent form approved by the University of Washington’s
Human Subjects Committee. Myoblasts were propagated
in F-10 medium (Invitrogen) containing 20% FBS, 1mM
dexamethasone and 10ng/ml basic ﬁbroblast growth
factor (Invitrogen), 100U/ml penicillin and 100mg/ml
streptomycin in ﬂasks coated with 0.7% gelatin and, for
H246, were supplemented with 1.3mM CaCl2 at 378Ci n
5% CO2. They were passaged when no more than about
80% conﬂuent (about 2.5 10
6 cells per T75 ﬂask).
Cultures used for experiments were checked by immuno-
cytochemistry to have 490% desmin-positive cells.
DNaseI treatment
Either cells (10
8 cells) that were permeabilized (LCLs) or
nuclei that were gently isolated (LCLs, myoblasts and
ﬁbroblasts) were treated with 0–200U/ml of DNaseI as
previously described (29,30) using minor modiﬁcations
given in the Supplementary Data. Then the DNA was
puriﬁed by RNase treatment and organic solvent extrac-
tion and stored in 10mM Tris–HCl, pH 7.4, 0.1mM
EDTA, pH 8.0.
Southern blot analysis
DNA was digested with restriction endonucleases and
probes were prepared by PCR or directly by excision from
recombinant plasmids as described previously (25) or in
the Supplementary Data. Complete digestion with restric-
tion endonucleases was veriﬁed for each sample with
an internal plasmid or phage DNA control (28). When
more than one probe was used with a blot, the lower-
copy-number probes were used ﬁrst and the blots were
checked for complete stripping before hybridizing to the
next probe.
For methylation analysis, tumors were scored for the
approximate extent of methylation change relative to
the somatic controls by phosphorimager quantitation and
assessment of band patterns from X-rays by methods
similar to those used previously (28). Scores for cancer
DNA methylation (methylation change) relative to diverse
somatic control tissues in the same blot were as follows: no
appreciable change (0), progressively more hypermethyla-
tion (+1, +2 or +3), or more hypomethylation ( 1,  2
or  3);  3 was strong hypomethylation, like that of
sperm, and +3 was little or no digestion with the CpG
methylation-sensitive restriction endonuclease (28). Some
blots were hybridized ﬁrst to the p13E-11 probe (7),
followed by stripping and rehybridizing to the D4Z4
probe. Where indicated, the percent methylation was
quantitated from the phosphorimager results of the
relevant bands, with normalization, when necessary,
for the percent overlap with the probe. Methods for
statistical analyses of the methylation data are described in
Supplementary Data.
For chromatin DNaseI sensitivity assays, the percent
remaining DNA (R) in the StyI parent fragment was
calculated from phosphorimager data as 100  the signal
in the parent fragment after DNaseI treatment divided by
that in parent fragment of the analogous sample incubated
with buﬀer instead of DNaseI. Where indicated, R values
for D4Z4, p13E-11, B2M, HMBS and IL-2 sequences
were normalized to the expected results for a parent band
of 1.5kb, the size of the CST5 and GHRHR parent bands.
This was done for each concentration of DNaseI in each
blot by using the near-linear slope of the plot of the size of
chromosome 1 satellite 2 (Sat2) parent bands (1.3, 1.7,
2.3 and 3.9kb) versus R for each of those bands. From
the slope, R values were extrapolated for hypothetical
Sat2 parent bands of 1.5kb (R1.5-kb Sat2) and the size of
the restriction fragment of interest. For B2M, with its
1.2kb StyI parent fragment, the normalization was
RB2M R1.5-kb Sat2/R1.2-kb Sat2. After quantitation, the
blots were stripped and checked for complete removal of
signal by phosphorimager analysis before hybridizing to
the next probe.
Analysis ofguanine quadruplex formation
D4Z4-derived oligonucleotides (5mM) were heated at
1008C for 10min, immediately placed on ice, incubated
at 378C for 48h in 0.1M KCl, 10mM Tris-HCl, pH 7.4,
and analyzed by circular dichroism spectropolarimetry
(CD; Jasco-810, Easton, MD) at 378C. A 1-mm optical
path length, a scanning speed of 50nm/min, and a
response time of 4s were used for the following
oligonucleotides: PQS6, 50-TGGGGGGGGGGGGTGG
GGGGGGA; PQS6-mut, 50-TGCGAGTGCGAGGTGA
GCGTGTA-30; and PQS5, 50-AGGGGGAGAGGGG
GGAGGGGGGAGGGGGGCGC-30. The average of
three scans was plotted after subtracting the buﬀer
baseline. Non-denaturing polyacrylamide gel electropho-
resis (PAGE) was done in a 20% gel at ambient
temperature after incubation of PQS 6 or PQS6-mut, as
above, subsequent to labeling with [g-
32P]ATP and
polynucleotide kinase.
RESULTS
D4Z4 arrays canbe hypo- orhypermethylated in cancers in
association withNBL2, aheterologous tandem repeat
To examine the nature of epigenetic changes in D4Z4
repeat arrays in cancers relative to various somatic con-
trol tissues, DNA samples were digested with the follow-
ing CpG methylation-sensitive enzymes: EagI (50-CGG
CCG-30), SmaI (50-CCCGGG-30), MluI (50-ACGCGT-30),
BstUI (50-CGCG-30), HpaII (50-CCGG-30), HpyCH4IV
(50-ACGT-30), or BsaAI (50-YACGTR-30). Either single
digests (EagI, SmaI and MluI) or double digests (BstUI,
HpaII, HpyCH4IV and BsaAI plus the CpG methylation-
insensitive enzymes KpnI or BglII) were used. After
checking all samples for complete digestion, they were
blot-hybridized to a 1-kb D4Z4 subfragment under
2198 Nucleic Acids Research, 2008, Vol. 36, No. 7stringent conditions speciﬁc for D4Z4 that did not give
interference from cross-hybridizing sequences (25). All
eight normal postnatal somatic tissues exhibited similar
blot-hybridization patterns indicating considerable, but
incomplete, methylation of D4Z4. In contrast, the 17
analyzed ovarian epithelial carcinomas and 44 Wilms
tumors displayed large diﬀerences in D4Z4 methylation
(Supplementary Figures 1–3; with summary data from
representative samples in Figure 2). As shown in the
summary of data from these 61 cancers (Table 1), most
specimens from both of these diverse types of cancers were
either signiﬁcantly hypo- or hypermethylated at D4Z4
EagI and SmaI sites relative to somatic control tissues
(P=0.015 and 0.00003 for ovarian carcinomas and
P=0.0006 and 0.00003 for Wilms tumors, respectively).
There was a strong association between alterations in
D4Z4 methylation at EagI and SmaI sites in both ovarian
carcinomas (P510
 6) and Wilms tumors (P510
 14).
Cancer-linked methylation changes at the other
examined CpG-containing restriction sites for a given
tumor were also very similar to those at EagI and SmaI
sites (Supplementary Figures 2A and 3A and data not
shown).
We also found that methylation changes in the
subtelomeric 4q and 10q D4Z4 arrays were signiﬁcantly
associated with those in the NBL2 repeats arrays, which
are located mostly in the short arms of the acro-
centric chromosomes. For this analysis, tumor-linked
methylation changes at EagI sites in the D4Z4 arrays
were compared with those previously described for HhaI
(50-GCGC-30) sites in NBL2 (1) using southern-
blot-derived methylation scores, that had been validated
by hairpin genomic sequencing (1). These sites are present
at similar densities (5 and 3 per 3.3- and 1.4-kb repeat
unit, respectively) and were analyzed in overlapping sets
of tumors (Table 1). This analysis included borderline
carcinomas (low malignant potential tumors) and
benign tumors (cystadenomas) of epithelial origin
(Supplementary Data). Alterations in D4Z4 methylation
in the group of all examined tumors were signiﬁcantly
associated with those of NBL2 (P50.0001, Kendall’s tau
correlation). There is probably a common recognition of
both dissimilar types of repeat arrays by poorly under-
stood pathways for demethylation and de novo methyla-
tion that function during tumorigenesis, just as both
tandem repeats are dependent on DNMT3B for normal
levels of methylation (1,20).
Spreadingof DNA methylation inD4Z4
Several of the cancers had extremely high levels of
methylation in consecutive 3.3-kb repeat units of D4Z4
arrays (Supplementary Figures 1–3). For example, the
amount of D4Z4 uncleaved by BstUI, HpaII or
HpyCH4IV in double digests with the CpG methylation-
insensitive KpnI was 52–88% for Wilms tumor 11 (WT11)
as compared with 7–14% for control brain DNA, even
Figure 2. Cancer-linked hyper- or hypomethylation in the bulk of the D4Z4 array, at the very beginning of the array, and immediately proximal to
the array in representative samples. The immediately proximal region includes the 0.8-kb p13E-11 sequence, which is 0.1kb from the beginning of the
D4Z4 array. The squares denote analyzed CpG methylation-sensitive restriction sites. The most proximal HpyCH4IV and BsaAI sites in the ﬁrst
repeat unit of the array are shown followed by a long rectangle representing the foreshortened remainder of the array. The height of the black ﬁll-in
is approximately proportional to the average extent of methylation. Methylation in the bulk of the D4Z4 array is diagrammed for HpyCH4IV sites
because the small number (six) of HpyCH4IV sites per 3.3-kb repeat unit facilitated quantitation. Other CpG-containing restriction sites were more
heavily methylated in somatic controls but gave hypo- or hypermethylation in cancers similar to that seen at HpyCH4IV sites. The gray vertical bars
in the D4Z4 array in cancer samples represent the subregion of the D4Z4 repeats units that is partially resistant to hypermethylation and located
about 1.4kb distal to the KpnI site (Figure 3A). See Supplementary Figures 1–3 for most of the data used in this ﬁgure.
Nucleic Acids Research, 2008, Vol. 36, No. 7 2199though BstUI and HpaII sites are respectively about 6 and
12 times as frequent as HpyCH4IV sites in D4Z4
(Supplementary Figure 2A). In single digests of WT11
or WT52 DNA with BstUI or HpyCH4IV, most of the
D4Z4 signal was in fragments of more than 10kb
(Figure 2 and data not shown). This indicates complete
methylation at these sites for at least three contiguous
repeat units. Because BstUI has 37 recognition sites per
D4Z4 repeat unit, the long fragments had more than 100
contiguous methylated sites. Other, much smaller, hybri-
dizing fragments were also present indicative of close
unmethylated sites in other portions of D4Z4. Not only
these two cancer DNA digests but also many other SmaI
digests of control and cancer DNAs displayed signiﬁcantly
non-random distributions of D4Z4 fragment sizes con-
sistent with long regions of these arrays being highly
methylated and other regions having little methylation
in the same sample (Supplementary Figure 1 and
Supplementary Data). These observations and the asso-
ciations between methylation at diﬀerent restriction sites
in D4Z4 suggest that methylation spreads along the arrays
during normal development and during tumorigenesis
with long regions of complete methylation and inter-
spersed regions of considerably lower methylation.
Amethylation-resistant subregion within each3.3-kb
repeat that containspotential G-quadruplexes
One subregion within the 3.3-kb D4Z4 repeat unit
displayed resistance to hypermethylation. An unexpect-
edly strong D4Z4-hybridizing band at the position of
1.4-kb fragments was seen in BstUI/KpnI and HpaII/
KpnI digests from the ﬁve examined cancers that had
hypermethylation of D4Z4 (WT11, WT52, WT5 and
ovarian carcinomas Q and S, Figure 2 and Supplementary
Figure 2A and B). This prominent band cannot be
explained by trivial reasons, e.g. the distribution of
BstUI and HpaII sites in D4Z4 (37 and 71 per 3.3-kb
repeat unit, respectively; Figure 3A). It was also observed
in BstUI/KpnI and HpaII/KpnI digests of somatic control
DNAs, although at a lower intensity, but not in cancer or
control samples singly digested with BstUI or HpaII.
Therefore, this 1.4-kb fragment should be derived from
cleavage at the single KpnI site in each D4Z4 repeat unit
and a subregion of the repeat unit located about 1.4kb
distal (Figure 3A). This subregion of the D4Z4 repeat
unit is apparently partly resistant to hypermethylation
in cancer.
The primary structure of D4Z4 in this subregion is very
unusual (Figure 3B). There is an uninterrupted run of 37
pyrimidine residues on the forward strand adjacent to
HpaII and BstUI sites located 1395 and 1409nt, respec-
tively, after the KpnI site of the 3.3-kb D4Z4 repeat unit.
Importantly, (G5N2-3)4, a potential guanine quadruplex
sequence (PQS5, Figure 3A and B), is complementary to
27nt of the Y37 sequence. Nearby is a (G3N2)4 sequence
(PQS6) that also ﬁts the PQS consensus sequence of
four equally long runs of G in the following context:
G3-5N1-7G3-5N1-7G3-5. PQS5, which is present 1412nt
after the KpnI site, scores especially high in a PQS predic-
tion program for intramolecular G-quadruplexes (31).
Table 1. Methylation change scores for ovarian epithelial tumors (carcinomas, LMP tumors, and cystadenomas) and Wilms tumors at EagIo rSmaI
sites in D4Z4 or HhaI sites in NBL2
a
Sample D4Z4
EagI
D4Z4
SmaI
NBL2
HhaI
Sample D4Z4
EagI
NBL2
HhaI
Sample D4Z4
EagI
D4Z4
SmaI
NBL2
HhaI
Sample D4Z4
EagI
D4Z4
SmaI
NBL2
HhaI
Controls
b 0 0 0 LMP 8 +1 nd WT1 0 0 +1 WT29  10 + 2
OvCa A 0 0 +1 LMP 9  1 0 WT4  2  2 +1 WT30 0 0 +2
OvCa B 0 0 +1 LMP 10 0 +1 WT5 +3 +2 +1 WT33  1Y + 2
OvCa C 0 0 0 LMP 11 0 0 WT6  2  3 +1 WT34 Y 0 +3
OvCa D  3  3  2 LMP 12 0 +2 WT7  1  1 +1 WT37 0 Y +2
OvCa E 0 0  1 LMP 13  1 nd WT8  1  1 +3 WT38  1  1+ 2
OvCa G  2  2  2 LMP 14 0 0 WT9 0 0 +1 WT39 +2 +1 +1
OvCa H  1  1 +1 LMP 15 0 +2 WT11 +2 +3 +3 WT40  1  1+ 1
OvCa I  1  2 +2 LMP 16 0 +2 WT13  1  1 +1 WT41  1  20
OvCa J  2  1 +1 LMP 19 0 +1 WT15 +1 +1 +3 WT42 0 0 +3
OvCa K 0 +1 +1 Cystad. 1  1 0 WT17 0 0 +1 WT44 Y 0 +1
OvCa L +1 +1 +1 Cystad. 2 0 0 WT18  1  1 +2 WT45  1  2n d
OvCa M 0 Y 0 Cystad. 3  1 +1 WT19 0 +1 +1 WT46  10 + 2
OvCa N +1 +1 +2 Cystad. 4 +1 +2 WT20 +1 +1 +3 WT47 +1 +1 0
OvCa O +1 Y +2 Cystad. 5  1 0 WT21 +1 0 +3 WT48  2  20
OvCa Q +3 +2 +3 Cystad. 6  1 0 WT22  2  2 +1 WT49  1  1n d
OvCa R 0  1 +1 Cystad. 7  1 0 WT23  1 Y +1 WT50 0 0 +2
OvCa S +2 +3 +2 Cystad. 10  1 0 WT24  2  2 +1 WT51 Y +1 +1
LMP 1  1 0 nd Cystad. 11 +1 nd WT25  1  1 0 WT52 +3 +2 +3
LMP 2 +1 +2 nd Cystad. 17 0 nd WT26 0 0 0 WT54 +2 +2 +3
LMP 3  1 nd nd Cystad. 20  1 nd WT27 +2 0 +1 WT57 +3 +3 +2
LMP 7 0 +1 nd Cystad. 21 0 nd WT28  1  1 +2 WT67  1  1+ 1
aOvarian carcinomas (OvCa), low malignant potential (LMP) tumors, and cystadenomas (cystad.) as well as Wilms tumors (WT) were scored for
methylation change by southern blotting relative to eight diverse somatic control tissues (controls). Scores:  1,  2, and  3, increasing
hypomethylation; +1, +2, and +3, increasing hypermethylation; 0, little or no change relative to controls; Y, change in the methylation pattern that
is diﬃcult to classify as hypo- or hypermethylation; nd, not determined. Supplementary Figure 1 shows representative blots, which illustrate the
hyper- or hypomethylation of most cancers compared to the similar patterns of methylation in the control somatic tissues.
bFour diverse somatic control tissues were present in each cancer DNA blot.
2200 Nucleic Acids Research, 2008, Vol. 36, No. 7Each 3.3-kb D4Z4 repeat unit contains seven PQS that
match the above consensus sequence (Figure 3A;
GenBank AF117653 and AC126281).
By CD spectroscopy, a single-stranded PQS5 or PQS6
oligonucleotide had a strong positive peak with a
maximum at 263nm and a negative peak centered
around 243nm (Figure 3C). A positive CD peak at
about 260nm and a negative peak at about 240nm are
diagnostic for G-quadruplexes, usually of the parallel type
(32) (Figure 3D). PQS6-mut, an oligonucleotide derived
from PQS6 but with nine substitutions of C, A or T for G
residues, gave a non-speciﬁc CD spectrum (Figure 3B
and C). Radiolabeled PQS6 and PQS6-mut oligonucleo-
tides were analyzed by non-denaturing PAGE. In addition
to a band that migrated as expected for the unstructured
oligonucleotide, about half of the signal from PQS6
was in low-mobility bands indicating intermolecular
G-quadruplexes (33) (data not shown). For PQS6-mut,
only one band with the expected mobility was seen.
Resistance toDNA hypermethylation inthe beginning
of theD4Z4 arrayand immediately proximal toit
We were able to compare methylation in the very
beginning of the D4Z4 array, in the bulk of this array,
and immediately proximal to it by hybridizing blots to a
p13E-11 probe, which is a D4Z4-adjacent sequence
(Figure 1), and then to the D4Z4 probe. This was done
for BstUI/KpnI, HpaII/KpnI, HpyCH4IV/KpnI and
BsaAI/BglII digests of cancer and control DNAs
(Supplementary Figures 2 and 3). While D4Z4 is
extremely rich in CpG’s (9.9% CpG), there are only six
CpG sites (0.6% CpG) in the 930-bp region immediately
proximal to D4Z4. This proximal region encompasses
the 0.8-kb p13E-11 sequence (Figure 1). Two of the
six proximal CpG’s are in HpyCH4IV and BstBI
recognition sites and were analyzed by southern blotting
(Supplementary Figure 2). Surprisingly, in cancers with
overall D4Z4 hypermethylation relative to somatic con-
trols, there was resistance to hypermethylation, and even
decreased methylation, in the ﬁrst approximately 2kb of
the array and immediately proximal to it (Figure 2).
A BstUI site located 2.1kb proximal to the array was the
exception (Figure 2). It was tenaciously methylated in all
cell populations, including sperm and WT22, which were
strongly hypomethylated at D4Z4 compared to somatic
controls (Figure 2 and Supplementary Figure 2C and D).
Conventional hairpin structures with T-A or T-G base-
pairing might form from the T2-5A4-5 sequence and the
Figure 3. Potential G-quadruplex sequences (PQS) in D4Z4. (A) Maps of the 3.3-kb D4Z4 repeat unit showing positions of PQS, BstUI and HpaII
sites, and the alignment of the unexpectedly strong 1.4-kb band that was observed in BstUI/KpnI and HpaII/KpnI digests (Supplementary Figure 2).
Diamonds, PQS; large for G5 and small for G3 runs; upward for those on the forward strand and downward for those on the complementary strand.
hhspm3, a sequence that can function as a promoter; DUX4, an open reading frame without a polyadenylation signal (15,16). (B) The D4Z4
subsequence (AF117653) that contains PQS5 and PQS6. Potential unimolecular G-quadruplex structures (blue or red) are shown but there are
variations possible in the exact placement of the four runs of G in this subregion that could be involved in unimolecular quadruplexes. In addition,
non-adjacent compatible runs of G might participate in quadruplex formation like that seen in bi- and tetramolecular G-quadruplexes. Purple, the
closest BstUI and HpaII sites to PQS5; green, mutated residues in PQS6-mut. (C) CD analysis of PQS5, PQS6 and PQS6-mut as single-stranded 23-
to 32-nt oligonucleotides. (D) Illustration of one possible orientation for G residues to stack and form a hairpin-type intramolecular G-quadruplex.
The numbering corresponds to PQS6 in Panel B, but various other conﬁgurations are possible that preserve the planar stacking of four G residues
connected by Hoogsteen pairing (dotted lines).
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respectively (Supplementary Figure 2E). This might help
recruit DNA methyltransferases (34) to keep the site
methylated.
Chromatin DNaseI sensitivity of D4Z4and immediately
proximal sequences
Given the unusual DNA methylation changes that we
found in and adjacent to this array in cancer and the
linkage of D4Z4 arrays to FSHD, we studied the
conformation of chromatin in these regions by DNaseI
sensitivity assays on cultured cells. Chromatin standards
(Supplementary Table 1) and the restriction enzyme for
digestion (StyI) of isolated DNA from DNaseI-treated
nuclei or permeabilized cells were chosen to allow
comparison of test sequences and euchromatin and
heterochromatin standards in a single southern blot. The
test sequences were 4q35 D4Z4, which is linked to FSHD;
10q26 D4Z4, which is phenotypically neutral; and p13E-
11 the sequence immediately proximal to D4Z4 (Figure 1).
Because FSHD is mostly a skeletal muscle disease, it was
important to test cells from the muscle lineage, namely,
FSHD and control myoblast cell strains. These non-
transformed cell cultures are generally diﬃcult to obtain,
generate and propagate and have limited growth potential
before irreversible growth arrest. Moreover, large num-
bers of cells (10
8) are required for one chromatin DNaseI
sensitivity assay monitored by southern blotting.
Therefore, we ﬁrst tested lymphoblastoid cell lines
(LCLs) and control ﬁbroblast cell strains. Lysolecithin
eﬃciently permeabilized LCLs, but not ﬁbroblasts, to
DNaseI (Supplementary Figure 4A). We were able to
study the chromatin DNaseI sensitivity of ﬁbroblasts and
myoblasts by incubating gently isolated nuclei with
DNaseI and adjusting DNaseI digestion conditions.
A comparison of permeabilized LCL cells and LCL
nuclei gave similar results for relative DNaseI sensitivity
of the analyzed DNA sequences (Supplementary Table 2).
The relative DNaseI sensitivity of standard and test
sequences in FSHD and control myoblasts, LCLs and
ﬁbroblasts was as follows: constitutively transcribed gene
standards (B2M and HMBS)4D4Z4-proximal p13E-11
marker4untranscribed gene standards (CST5, IL-2 and
GHRHR)44q and 10q D4Z44Sat2 juxtacentromeric
heterochromatin in chromosome 1 (Figures 4 and 5 and
Supplementary Figures 4B and 5). B2M and HMBS are
highly transcribed in all studied tissues while CST5, IL-2
and GHRHR are selectively transcribed in only a small
number of cell types, not including those in this study
(http://www.genecards.org/ and http://expression.gnf.org/
cgi-bin/index.cgi). The diﬀerences in DNaseI digestion
for untranscribed gene standards versus transcribed gene
standards and constitutive heterochromatin versus
untranscribed gene standards were signiﬁcant (P510
 4).
It was very surprising that p13E-11, which is only
0.1kb from D4Z4 (Figure 1) and has no features of
a gene (http://exon.gatech.edu/GeneMark/, http://www.
softberry.com/berry.phtml, and http://genes.mit.edu/
GENSCAN.html), was more sensitive to DNaseI than
the untranscribed gene standards in all tested myoblast,
ﬁbroblast and lymphoblastoid cell or nuclei populations
(P510
 4).
In every studied cell type, both the 3.3- and 2.8-kb
D4Z4 parent bands from 4q35 and 10q26, respectively
(Figure 1B), were much more resistant to DNaseI than the
1.9-kb region containing the p13E-11 sequence (P510
 5;
Figures 4 and 5). In addition, the D4Z4 arrays were more
resistant to DNaseI than untranscribed gene standards
and less than the constitutive heterochromatin standard in
every FSHD and control cell population (P510
 4 for
both comparisons). Similar results were obtained with or
without normalization for the somewhat diﬀerent sizes of
the parent fragments (1.2–3.3kb; Supplementary Table 2).
No DNaseI hypersensitive sites (discrete lower-molecular-
weight bands) were seen in the promoter regions or other
tested sequences. However, this might be due to optimiz-
ing conditions for measuring general DNaseI sensitivity
rather than hypersensitive sites.
Among the two studied pairs of similar standards,
namely, the untranscribed and the constitutively tran-
scribed gene standards, smaller, but also signiﬁcant
diﬀerences, were seen (P510
 3, Figures 4 and 5). CST5
Figure 4. The D4Z4-adjacent p13E-11 marker sequence is more accessible to DNaseI than untranscribed gene standards and much more accessible
than D4Z4 in myoblast nuclei. The size-normalized (Supplementary Table 2) percentage of DNA remaining in the parent StyI restriction fragment is
shown for each examined DNA sequence in DNaseI-treated nuclei from control fetal myoblasts (A) and FSHD myoblasts (B).
2202 Nucleic Acids Research, 2008, Vol. 36, No. 7was slightly more resistant to DNaseI than GHRHR in all
samples although both genes should be untranscribed in
the examined cells. Similarly, the ubiquitously transcribed
B2M was always appreciably more resistant to DNaseI
than the other constitutively expressed standard, HMBS.
This might reﬂect gene-speciﬁc diﬀerences in chromatin
structure even when comparing genes with the same
expression status. Given the reproducibility of these
ﬁndings among diﬀerent cell populations, it is noteworthy
that 10q D4Z4 chromatin was generally a little more
resistant to DNaseI than 4q D4Z4 chromatin (P=10
 3,
Figures 4 and 5).
The length of the D4Z4 arrays needs to be considered in
evaluation of their chromatin DNaseI sensitivity because
of the frequent correlations between long tandem repeat
arrays and heterochromatinization (35,36) and the eﬀect
of the size of 4q D4Z4 arrays on disease status. We looked
for correlations of DNaseI chromatin resistance and
D4Z4 array size as determined by pulsed-ﬁeld gel
electrophoresis (25). Interpretation of the results is
complicated by large D4Z4 arrays contributing propor-
tionally more signal than short arrays and the highly
polymorphic sizes of these arrays. The most informative of
our studied cell populations to look for an eﬀect of D4Z4
array length on the DNaseI resistance was the control
LCL 724. It has two short 10q D4Z4 arrays (6- and 10-
unit) and two long allelic 4q arrays (both 27 repeat units).
The 2.8-kb band from 10q D4Z4 was well separated from
the 3.3-kb band from 4q D4Z4. Because 10q and 4q D4Z4
arrays are almost identical in sequence (26), if the
chromatin structure of 10q D4Z4 is dependent on the
length of the array, this is probably also true for 4q D4Z4.
Contrary to a simple correlation between array size and
DNaseI resistance, the 10q and 4q D4Z4 arrays of LCL
724 had virtually the same DNaseI resistance (Figure 5
and Supplementary Table 2).
DISCUSSION
A major unanswered question about the molecular
genetics of FSHD is how a tandem array of more than
ten 3.3-kb D4Z4 units at both 4q35 allelic positions is
almost always protective against the disease while one
4q35 D4Z4 array with ten or fewer repeat units usually
indicates the presence of the disease by the third decade
(37). The in situ ‘ruler’ or biochemical device for
Figure 5. D4Z4 chromatin is quite resistant and the adjacent p13E-11 chromatin is very sensitive to DNaseI in all studied FSHD and control cell
populations. Nuclei (FSHD myoblasts, control fetal myoblasts, one control ﬁbroblast cell strain) or permeabilized cells (LCLs) were treated with four
or ﬁve diﬀerent concentrations of DNaseI. The results are given for only one concentration of DNaseI (20, 50 or 100U/ml) but these are
representative of the results at each concentration (e.g. Figure 4) and all diﬀerences in sensitivity between diﬀerent types of DNA sequences were
highly signiﬁcant (P510
 4, see text). The analyzed DNA sequences for each cell type are as follows, from left to right in each bar graph: two
untranscribed gene standards (Untr, CST5 and GHRHR), p13E-11 (11; bar denoted by a vertical arrow), D4Z4 (D4, 4q-type and 10q-type arrays),
constitutively transcribed gene standards (Tr, B2M and HMBS), and the constitutive heterochromatin standard (Sat2). After size normalization, the
percentage of DNA remaining in the parent band for each sequence was divided by that for the average of the untranscribed standards.
In parentheses is the number of copies of the D4Z4 repeat unit for the allelic 4q-type arrays (no BlnI site and a single StyI site per 3.3kb) and the
allelic 10q-type arrays (one BlnI site and two StyI sites per 3.3kb) (51). The control myoblasts and the ﬁbroblasts had one of the 4q D4Z4 arrays
replaced by a canonical 10q-type array, as is seen in some individuals, but this has no eﬀect on phenotype (51).
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likely to involve topological diﬀerences between a short
array and one containing more than ten units. However,
the nature of D4Z4 chromatin is little understood.
We previously reported on histone H4 acetylation of
D4Z4 and proximal sequences (8). Histone acetylation is
often inversely related to local chromatin compaction (38),
although not always (39). D4Z4 chromatin in several
human chromosome 4-containing somatic cell hybrids has
low levels of H4 acetylation, but not as low as those of a
heterochromatin standard. Those PCR-dependent experi-
ments were conﬁned to somatic cell hybrids because of the
lack of primers speciﬁc for D4Z4 (8). Histone acetylation
at p13E-11, the immediately proximal sequence to D4Z4,
was at levels similar to those of untranscribed genes rather
than to constitutive heterochromatin.
Here we analyzed the general DNaseI sensitivity of
D4Z4 and the immediately proximal region under blot-
hybridization conditions speciﬁc for these sequences
(7,25). The DNaseI sensitivity of both 4q and 10q D4Z4
chromatin was intermediate to that of constitutive
heterochromatin and inactive genes in FSHD and control
myoblasts, ﬁbroblasts and lymphoblastoid cell lines.
A caveat is that in comparing short, disease-associated
D4Z4 arrays with normal, long D4Z4 arrays, the
contribution of the short array to the blot-hybridization
signal is obscured by the proportionally greater contribu-
tion of the long arrays. However, in a control LCL (724,
Figure 5), two short allelic D4Z4 arrays at 10q (6 and 10
repeat units) were not more sensitive to DNaseI than two
long 4q D4Z4 arrays (both 27 repeat units) or than
untranscribed gene standards. These results suggest a high
degree of condensation of D4Z4 chromatin even in short,
FSHD-sized repeat arrays, with the caveat that DNaseI
sensitivity measures only certain aspects of higher-order
chromatin structure.
It has been proposed that heterochromatinization
spreads proximally from a normal, long D4Z4 array to a
4q35 gene responsible for initiating the FSHD dysregula-
tion cascade (14,40,41). Contrary to that hypothesis or the
idea that long D4Z4 arrays might normally act as
insulators (5,41), the region immediately proximal to
the D4Z4 array (p13E-11) was more sensitive to DNaseI
than the bulk D4Z4 array in all tested cell cultures.
Unexpectedly, this D4Z4-adjacent region consistently
displayed a DNaseI sensitivity that was even greater
than that of untranscribed gene standards. We found no
predicted promoter, enhancer, or exon in the 4-kb region
proximal to the 4q or 10q D4Z4 arrays that could explain
its unexpectedly high sensitivity to DNaseI even in control
ﬁbroblasts containing four long D4Z4 arrays (18–30
repeat units per array). The nuclease sensitivity in this
region might reﬂect a local strain in the chromatin
conformation.
We could monitor the DNaseI sensitivity of the D4Z4-
proximal region and the average sensitivity of the D4Z4
array but not speciﬁcally that of the ﬁrst D4Z4 repeat unit.
However, by studying cancer-linked DNA methylation
changes, we found evidence for an atypical chromatin
structure at the beginning of the D4Z4 array and
immediately proximal to it. The apparent spreading of
methylation along D4Z4 that we observed seems to have
limits to its processivity and to be prone to stop at certain
subregions. Speciﬁcally, there was a remarkable resistance
to cancer-linked hypermethylation at the very beginning
of the repeat array and at several CpG sites proximal to
the array in cancers that displayed strong hypermethyla-
tion in the bulk of the array (Figure 2). The sequence of
D4Z4 repeat units is highly conserved throughout the
array. Therefore, the diﬀerential susceptibility to tumor-
linked hypermethylation at the start of the array versus in
the bulk of the array is best explained by a special
chromatin structure at the junction of D4Z4 and the
proximal non-repeated sequence.
The methylation and DNaseI sensitivity ﬁndings
suggest that there is a boundary element (42) (Figure 6)
around the junction of the D4Z4 array and the
immediately proximal sequence. Naturally occurring
deletions of this D4Z4-proximal region indicate that the
exact sequence immediately proximal to D4Z4 cannot be
contributing to the phenotype (43). However, there might
be a critical interfacing of D4Z4 (ﬁrst 200bp, 78% G+C)
and a DNA sequence with a more typical base composi-
tion for human DNA (immediately proximal 200bp,
43.5%).
The second region in which we observed resistance to
cancer-linked hypermethylation is a subregion of the
3.3-kb D4Z4 repeat unit, about 1.4kb distal to its single
KpnI site. It has runs of G residues that are predicted to
form stable G-quadruplexes (Figure 3B). We demon-
strated that two of these sequences, PQS5 and PQS6,
readily form G-quadruplexes when tested as single-
stranded oligonucleotides. Inhomogeneous spreading of
DNA methylation along the body of the D4Z4 arrays
might be due partly to such unusual DNA secondary
structures within the D4Z4 repeat units hindering the
spread of DNA methylation in vivo directly or indirectly,
by eﬀects on chromatin structure.
Various types of indirect evidence suggest that genomic
G-quadruplexes, non-B DNA structures, exist in vivo and
mediate transcription control, genomic stability and
chromatin packing at telomeres (44,45). In certain
functional classes of genes, including those associated
with muscle development or contraction, PQS over-
representation is especially high (46), which is further
evidence for their biological relevance. G-quadruplexes
can involve Hoogsteen base-pair interactions between
runs of G residues within one local sequence on a DNA
strand (Figure 3D) or between four equal-length runs of G
residues on two or four diﬀerent strands (44,47). They
might also form between two runs of G residues in non-
neighboring locations within the same region of a given
strand and thereby help establish higher-order packing of
chromatin (45).
We propose that G-quadruplex formation in the 3.3-kb
D4Z4 repeat unit (Figure 3A) helps organize D4Z4
chromatin to give special intra-array looping in normal,
long arrays (Figure 6). We further hypothesize that, within
short arrays, abrogation of this intra-array looping allows
long-distance looping between the beginning of the array
and an FSHD master gene at 4q35 (Figure 6). The identity
of this 4q35 gene is still uncertain despite many
2204 Nucleic Acids Research, 2008, Vol. 36, No. 7conventional analyses (8,14–16), including microarray
expression studies (11–13). The postulated alternative
looping to regulate expression of the FSHD master gene
could explain why only short D4Z4 arrays at 4q35 are
linked to FSHD by permitting long-distance looping that
initiates inappropriate gene expression accounting for the
dominant inheritance of this disease.
The hypothesized boundary element at the ﬁrst D4Z4
repeat unit in normal and FSHD cells (Figure 6) makes it
easier to envision pathogenic long-distance chromatin
interactions between a short D4Z4 array at 4q35 and
another FSHD-related DNA sequence in cis. Given
that FSHD is mostly a muscle-speciﬁc disease, it is
intriguing that the myogenesis-speciﬁc homodimeric
MyoD protein can speciﬁcally recognize G-quadruplexes
with a higher aﬃnity than speciﬁc duplex sequences
(48–50). That this transcription factor preferentially
binds to G-quadruplexes between runs of G on diﬀerent
oligonucleotide strands makes the above model a very
attractive hypothesis for understanding part of the
perplexing near-threshold eﬀect of D4Z4 array size on
disease status such that a 4q35 D4Z4 array of511 repeat
units (536kb) is diagnostic for FSHD.
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